niddk-tirzepatide slimming & health nano microneedle patch ๐๐ผ๐ป๐ ๐ถยฎ ๐ก๐๐๐๐-๐ง๐ถ๐ฟ๐๐ฒ๐ฝ๐ฎ๐๐ถ๐ฑ๐ฒ ๐ก๐ฎ๐ป๐ผ ๐ ๐ถ๐ฐ๐ฟ๐ผ๐ป๐ฒ๐ฒ๐ฑ๐น๐ฒ ๐ฃ๐ฎ๐๐ฐ๐ต Lmipki Trzepatide Nano Microneedle Patch
Description
In the head-to-head SURMOUNT-5 trial (NEJM 2025), tirzepatide produced 20.2% weight loss vs 13.7% for semaglutide at 72 weeks
Most healthcare providers recommend a structured dose reduction over 8 to 16 weeks for the best long-term outcomes
Notably, the reduction in insulin dose was primarily driven by glucose response and insulin pump algorithm
The fact that similar dosages were not used in the two groups, however, could effect the actual outcome of this study
